Literature DB >> 23298884

Whole anterior segment proton beam radiotherapy for diffuse iris melanoma.

Lazaros Konstantinidis1, Dawn Roberts, R Douglas Errington, Andrzej Kacperek, Bertil Damato.   

Abstract

AIM: To report the results of whole anterior segment proton beam radiotherapy (PBR) for diffuse iris melanoma.
METHODS: Between 2000 and 2011, 12 patients with iris melanoma received PBR to the entire iris and ciliary body.
RESULTS: Patients had a mean age of 57 years and a median follow-up of 3.5 years (range 1-11.6 years). Tumour iris involvement was 1-4 h in five patients, 5-8 h in four and 9-12 h in three. Angle involvement was 6-8 h in five patients and 9-12 h in seven. The visual acuity (VA) before treatment was 6/5-6/6 in six patients, 6/8-6/9 in three and 6/18-6/38 in three. No tumour recurrence occurred during the follow-up period. Glaucoma treatment was required in 11 of 12 patients. The visual acuity at the last follow-up was 6/5-6/9 in five patients, 6/18-6/24 in three, 6/60-1/60 in two and no light perception in two. Four patients developed varying non-severe degrees of limbal stem cell deficiency, which was treatable with conservative measures.
CONCLUSIONS: Whole anterior segment PBR is a useful alternative to enucleation for diffuse iris melanoma. Most patients will need treatment for glaucoma and some may require treatment for tear-film instability and/or stem cell failure.

Entities:  

Mesh:

Year:  2013        PMID: 23298884     DOI: 10.1136/bjophthalmol-2012-302659

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.

Authors:  Aline I Riechardt; Bettina Karle; Dino Cordini; Jens Heufelder; Volker Budach; Antonia M Joussen; Johannes Gollrad
Journal:  Strahlenther Onkol       Date:  2017-06-19       Impact factor: 3.621

2.  Proton beam radiotherapy of uveal melanoma.

Authors:  Bertil Damato; Andrzej Kacperek; Doug Errington; Heinrich Heimann
Journal:  Saudi J Ophthalmol       Date:  2013-07

3.  [Iridal color changing in ocular masquerade syndrome].

Authors:  S Waibel; K Pillunat; L Pillunat
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

4.  Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.

Authors:  Aline I Riechardt; Julian P Klein; Dino Cordini; Jens Heufelder; Matus Rehak; Ira Seibel; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-20       Impact factor: 3.117

5.  The surgical approach to the management of anterior uveal melanomas.

Authors:  I Rospond-Kubiak; B Damato
Journal:  Eye (Lond)       Date:  2014-04-11       Impact factor: 3.775

6.  Novel Eye Plaque Designs for Brachytherapy of Iris and Ciliary Body Melanoma and the First Clinical Application.

Authors:  Wu Liu; Jenna May Kim; Benjamin K Young; Ravinder Nath; Zhe Chen; Roy H Decker; Melvin A Astrahan; Renelle Pointdujour-Lim
Journal:  Ocul Oncol Pathol       Date:  2018-10-11

Review 7.  Diffuse Iris Melanoma: Conservative Treatment with Proton Beam Therapy after Limbal Stem Cell Preservation or Enucleation?

Authors:  Alice Leblanc; Livia Lumbroso-Le Rouic; Laurence Desjardins; Rémi Dendale; Nathalie Cassoux
Journal:  Ocul Oncol Pathol       Date:  2019-03-20

8.  Iris melanoma relapsing sixteen years after proton-beam therapy: The importance of lifelong follow-up.

Authors:  Laetitia-Claire Msika; Laurence Desjardins; Vincent Cockenpot; Rémi Dendale; Olivier Berges; Khadija Aït Raïs; Gaëlle Pierron; Raymond L Barnhill; Nathalie Cassoux; Alexandre Matet
Journal:  Am J Ophthalmol Case Rep       Date:  2018-12-06

9.  Current molecular and clinical insights into uveal melanoma (Review).

Authors:  Matteo Fallico; Giuseppina Raciti; Antonio Longo; Michele Reibaldi; Vincenza Bonfiglio; Andrea Russo; Rosario Caltabiano; Giuseppe Gattuso; Luca Falzone; Teresio Avitabile
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

10.  Locally Invasive Diffuse Iris Ring Melanoma Presenting as Unilateral Severe Glaucoma: Case Report and Review of Molecular Genetics.

Authors:  Mina M Naguib; Patricia Chévez-Barrios; Silvia Orengo-Nania; Amy C Schefler
Journal:  Case Rep Oncol       Date:  2021-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.